2.7.1. Patients and doctors do not receive medications and medical devices in a timely manner and in full, in particular due to the incomplete transition to the new system of organization and control of medical procurement, and the incomplete regulation of the processes of identifying the needs for and accounting of medications

Information about the problem

expected strategic
results 7

measures 21

Progress in the implementation of measures as of 28.03.2025

All measures of the SACP

measures, the implementation of which as of 31.12.2024

is about to begin to be completed

10 4 4 1 2

Implemented Partially implemented In progress Not implemented Not started

Якісний рівень досягнення ОСР

1 3 42.9%
High

2 28.6%
Middle

2 28.6%
Low

Середня оцінка досягнення ОСР, %

48.6
%

Аналіз досягнення ОСР

Convenient search for measures

Display in tabular form

Expected strategic results

the diagrams above show the share (%) of completed measures (fully and partially)

% of measures implemented — % of measures partially implemented — evaluation of achievement of ESR, % —

2.7.1.1. Procurement of medications and medical devices at the expense of the state and local budgets is carried out on a professional basis by centralized procurement organizations under transparent and detailed procedures in accordance with objective needs based on the quality and evidence of effectiveness of such products and devices. If necessary, specialized international organizations are also involved in centralized procurement

40%

40.0%

Measure
2.7.1.1.1 Measure
2.7.1.1.2 Measure
2.7.1.1.3 Measure
2.7.1.1.4 Measure
2.7.1.1.5

2.7.1.2. All state and municipal healthcare institutions have implemented an electronic system for accounting of medications and medical devices, based on which transparent and detailed methods and systems for calculating the needs in all areas of procurement have been developed; this accounting system has been integrated into the electronic healthcare system, which provides additional data verification tools; information from this system is published in open data format

25%

0.0%

* Measure
2.7.1.2.1 * Measure
2.7.1.2.2 * Measure
2.7.1.2.3 * Measure
2.7.1.2.4

2.7.1.3. The specific considerations of procurement of medications and medical devices necessitated by the pandemic or carried out during the pandemic are established in such a way as to prevent corruption risks

100%

90.0%

Measure
2.7.1.3.1 Measure
2.7.1.3.2 Measure
2.7.1.3.3 Measure
2.7.1.3.4 Measure
2.7.1.3.5

2.7.1.4. Ukrainian procurement organizations engaged in the procurement of medications and medical devices have independent supervisory boards

100%

Measure
2.7.1.4.1

2.7.1.5. Standard catalogs and requirements for products procured in the healthcare sector are used in the procurement process

50%

0.0%

Measure
2.7.1.5.1 Measure
2.7.1.5.2

2.7.1.6. Clear rules and procedures have been established for identifying and resolving conflicts of interest of members of working and expert groups (primarily those that support the procurement of medical products at the expense of the state budget and determine the lists of products to be procured), and their strict observance in practice is ensured

80%

40.0%

Measure
2.7.1.6.1 Measure
2.7.1.6.2 Measure
2.7.1.6.3 Measure
2.7.1.6.4 Measure
2.7.1.6.5

2.7.1.7. Clear ethical rules of interaction between pharmaceutical companies and healthcare professionals have been defined, which make it impossible to abuse the prescription of medicines to patients; legal liability for violations of these rules has been established

33.3%

70.0%

Measure
2.7.1.7.1 Measure
2.7.1.7.2 Measure
2.7.1.7.3

* - certain measures are common to several ESRs, but have a separate number (id)